Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Total Liabilities
Glenmark Life Sciences Ltd
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Total Liabilities
₹5.6B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Liabilities
₹106.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Total Liabilities
₹60.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
6%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Liabilities
₹196.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
8%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Total Liabilities
₹94.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
8%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Liabilities
₹80.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
10%
|
See Also
What is Glenmark Life Sciences Ltd's Total Liabilities?
Total Liabilities
5.6B
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Total Liabilities amounts to 5.6B INR.
What is Glenmark Life Sciences Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-16%
Over the last year, the Total Liabilities growth was 0%. The average annual Total Liabilities growth rates for Glenmark Life Sciences Ltd have been -23% over the past three years , -16% over the past five years .